← All research updates

Focused brain radiation with immunotherapy did better than whole brain radiation in a lung cancer study

Original title: Stereotactic versus whole-brain radiotherapy combined with immunotherapy in driver gene-negative NSCLC with brain metastases: a real-world IPTW analysis.

How far along is this research?

This was tested in people. That is the most reliable kind of research we share.

Both treatments are already used in people, but this was a look back at patient records, not a planned trial.

The short version

People who got focused radiation to their brain tumors plus immunotherapy lived longer than people who got radiation to the whole brain.

What was studied. Doctors at one hospital in China looked back at the records of 158 people with non small cell lung cancer that had spread to the brain. All of them had tumors without the driver gene changes, and all got brain radiation plus immunotherapy. The doctors compared focused radiation to a few spots with radiation to the whole brain.

What they found. In the focused radiation group, the typical time people lived was 29.3 months. In the whole brain group it was 19.9 months. The typical time before the brain tumors grew again was 14.7 months with focused radiation and 9.4 months with whole brain radiation. Brain tumors shrank in 78.6% of the focused radiation group and 61.5% of the whole brain group, and brain injury from radiation was written down in 3.75% versus 10.26%.

What this means, and what it doesn't

What it could mean: If your lung cancer has spread to the brain, the type of radiation you get may matter. For some people, focused radiation to a small number of spots may be a better choice than treating the whole brain. This is worth asking your cancer doctor about, since the right choice depends on how many tumors you have and where they are.

What it doesn't mean: This does not mean focused radiation is right for everyone. This was a look back at old records from one hospital, not a study where people were randomly assigned to a treatment. That kind of study can be thrown off by things the doctors could not measure, so it cannot prove that the radiation type caused the difference. It is not a cure, and it does not mean anyone is free of cancer. It also does not apply to tumors that start in the brain, only to lung cancer that spread there.

Source: PubMed, June 22, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary